Insmed (INSM) Misses Q3 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. BA
6. META
7. SPY
8. INTC
9. JBLU
10. HOOD

Go back to Insmed (INSM) Misses Q3 EPS by 3c

UBS Downgrades Insmed (INSM) to Neutral; Arikayce Becomes a 2017 Story

November 9, 2015 7:59 AM EST

UBS downgraded Insmed (NASDAQ: INSM) from Buy to Neutral with a price target of $18.00 (from $35.00) based on a SOTP as Arikayce becomes a 2017 story.

Analyst Matthew Roden commented, "Insmed reported 3Q results and an incrementally negative update to the enrollment progress... More

US NTM Delayed Up to 12 Months; Cowen Cuts Price Target on Insmed (INSM) to $34

November 9, 2015 6:46 AM EST

Cowen reiterated an Outperform rating on Insmed (NASDAQ: INSM), and cut the price target to $34.00 (from $38.00), folloiwng the company's 3Q15 earnings report. INSM reported Q3 EPS of ($0.50) vs consensus ($0.47). Cowen's lower price target on INSM is based on a potential 12 month delay... More